Morgan Stanley Direct Lending Fund
MSDL NYSE Financials FY2021–FY2025
Last close · Oct 23, 2026
$13.22
0.2%What Morgan Stanley Direct Lending Fund does
No business description yet.
- Legal name
- Morgan Stanley Direct Lending Fund
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Feb 26, 2026
- Accession · CIK
- 0001193125-26-076632
0001782524
Revenue and margins
Morgan Stanley Direct Lending Fund had $397M of revenue in fiscal 2025, down 4.5% on the year before.
Net income and earnings per share
From fiscal 2021 to 2025, diluted EPS grew −14.9% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was — in fiscal 2025, — of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Morgan Stanley Direct Lending Fund returned $226M to shareholders in fiscal 2025. The diluted share count fell 1.6%.
Balance sheet
Cash, debt and the ratios that show how comfortably Morgan Stanley Direct Lending Fund can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $74.2M | $81.2M | $69.7M | $72.4M | $94.4M |
| Debt incl. finance leases | — | $1.5B | $1.5B | $2.0B | $2.1B |
| Debt / equity | — | 1.1x | 0.9x | 1.1x | 1.2x |
| Total assets | — | $3.0B | $3.3B | $3.9B | $3.9B |
| Total liabilities | — | $1.6B | $1.6B | $2.1B | $2.2B |
| Shareholders' equity | $1.2B | $1.4B | $1.7B | $1.8B | $1.7B |
| Net debt (− = net cash) | — | $1.4B | $1.4B | $1.9B | $2.0B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. “Plan” marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
| Test | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Net income is positive | ✓ | ✓ | ✓ | ✓ | ✓ |
| Cash from operations is positive | ✕ | ✕ | ✕ | ✕ | ✓ |
| Return on assets rose | — | — | ✓ | ✕ | ✕ |
| Cash from operations exceeds net income | ✕ | ✕ | ✕ | ✕ | ✓ |
| Debt fell relative to assets | — | — | ✓ | ✕ | ✕ |
| Current ratio rose | — | — | — | — | — |
| Share count didn't rise | — | ✕ | ✕ | ✕ | ✓ |
| Gross margin rose | — | — | — | — | — |
| Revenue rose relative to assets | — | — | ✓ | ✕ | ✕ |
| F-score | — / 3 | — / 4 | 4 / 7 | 1 / 7 | 4 / 7 |
| Accruals ratio | — | 16.0% | 10.0% | 16.6% | −0.7% |
| Altman Z'' | — | — | — | — | — |
5 years of figures
Amounts in USD. Hover a ratio’s name for its definition.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $120M | $231M | $368M | $416M | $397M |
| Interest expense | $21.0M | $67.2M | $113M | $123M | $136M |
| Net income | $83.3M | $48.5M | $231M | $216M | $122M |
| Diluted EPS | $2.67 | $0.79 | $3.11 | $2.43 | $1.40 |
| Diluted shares | 0.03B | 0.06B | 0.07B | 0.09B | 0.09B |
| Cash flow | |||||
| Cash from operations | −$1.7B | −$430M | −$83.8M | −$383M | $151M |
| Share buybacks | — | $0.0M | $0.0M | $18.1M | $42.0M |
| Dividends paid | $38.2M | $85.7M | $110M | $169M | $184M |
| Dividends and buybacks | $38.2M | $85.7M | $110M | $187M | $226M |
| Balance sheet | |||||
| Cash and short-term investments | $74.2M | $81.2M | $69.7M | $72.4M | $94.4M |
| Total debt | — | $1.5B | $1.5B | $2.0B | $2.1B |
| Total assets | — | $3.0B | $3.3B | $3.9B | $3.9B |
| Total liabilities | — | $1.6B | $1.6B | $2.1B | $2.2B |
| Preferred stock | — | $0.0M | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | $1.2B | $1.4B | $1.7B | $1.8B | $1.7B |
| Margins | |||||
| Net margin | 69.5% | 21.1% | 62.8% | 51.8% | 30.7% |
| Returns | |||||
| Return on equity | 7.0% | 3.8% | 14.8% | 12.1% | 6.8% |
| Return on assets | — | 1.6% | 7.3% | 6.0% | 3.1% |
| Return on tangible equity | 7.0% | 3.5% | 13.4% | 11.7% | 7.0% |
| Growth | |||||
| Revenue growth | — | 92.5% | 59.5% | 13.1% | −4.5% |
| Net income growth | — | −41.7% | 375.9% | −6.7% | −43.4% |
| EPS growth | — | −70.4% | 293.7% | −21.9% | −42.4% |
| Share count change | — | 97.9% | 20.4% | 19.4% | −1.6% |
| Financial health | |||||
| Debt / equity | — | 1.1x | 0.9x | 1.1x | 1.2x |
| Quality scores | |||||
| Piotroski F-score | — | — | 4.0 | 1.0 | 4.0 |
| Accruals ratio | — | 16.0% | 10.0% | 16.6% | −0.7% |
Source: SEC EDGAR XBRL filings (CIK 0001782524). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.
